| Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study MA Perera, LH Cavallari, NA Limdi, ER Gamazon, A Konkashbaev, ... The Lancet 382 (9894), 790-796, 2013 | 305 | 2013 |
| Genetic and clinical predictors of warfarin dose requirements in African Americans LH Cavallari, TY Langaee, KM Momary, NL Shapiro, EA Nutescu, ... Clinical Pharmacology & Therapeutics 87 (4), 459-464, 2010 | 239 | 2010 |
| The Missing Association: Sequencing‐Based Discovery of Novel SNPs in VKORC1 and CYP2C9 That Affect Warfarin Dose in African Americans MA Perera, E Gamazon, LH Cavallari, SR Patel, S Poindexter, RA Kittles, ... Clinical Pharmacology & Therapeutics 89 (3), 408-415, 2011 | 126 | 2011 |
| A polymorphism in the VKORC1 regulator calumenin predicts higher warfarin dose requirements in African Americans D Voora, DC Koboldt, CR King, PA Lenzini, CS Eby, R Porche‐Sorbet, ... Clinical Pharmacology & Therapeutics 87 (4), 445-451, 2010 | 125 | 2010 |
| Decreased Warfarin Clearance Associated With the CYP2C9 R150H (*8) Polymorphism Y Liu, H Jeong, H Takahashi, K Drozda, SR Patel, NL Shapiro, ... Clinical Pharmacology & Therapeutics 91 (4), 660-665, 2012 | 108 | 2012 |
| Poor warfarin dose prediction with pharmacogenetic algorithms that exclude genotypes important for African Americans K Drozda, S Wong, SR Patel, AP Bress, EA Nutescu, RA Kittles, ... Pharmacogenetics and genomics 25 (2), 73-81, 2015 | 94 | 2015 |
| Searching for the Optimal Treatment for Metallo-and Serine-β-Lactamase Producing Enterobacteriaceae: Aztreonam in Combination with Ceftazidime-avibactam or Meropenem-vaborbactam. M Biagi, T Wu, M Lee, S Patel, D Butler, E Wenzler Antimicrobial agents and chemotherapy, AAC. 01426-19, 2019 | 87 | 2019 |
| Ethnicity-specific pharmacogenetics: the case of warfarin in African Americans W Hernandez, ER Gamazon, K Aquino-Michaels, S Patel, TJ O'Brien, ... The pharmacogenomics journal 14 (3), 223-228, 2014 | 80 | 2014 |
| Effect of NQO1 and CYP4F2 genotypes on warfarin dose requirements in Hispanic–Americans and African–Americans A Bress, SR Patel, MA Perera, RT Campbell, RA Kittles, LH Cavallari Pharmacogenomics 13 (16), 1925-1935, 2012 | 74 | 2012 |
| Genetic variant in folate homeostasis is associated with lower warfarin dose in African Americans R Daneshjou, ER Gamazon, B Burkley, LH Cavallari, JA Johnson, ... Blood, The Journal of the American Society of Hematology 124 (14), 2298-2305, 2014 | 73 | 2014 |
| Pharmacogenetic associations of the type-3 metabotropic glutamate receptor (GRM3) gene with working memory and clinical symptom response to antipsychotics … JR Bishop, JL Reilly, MSH Harris, SR Patel, R Kittles, JA Badner, ... Psychopharmacology 232, 145-154, 2015 | 63 | 2015 |
| Antipsychotic pharmacogenomics in first episode psychosis: a role for glutamate genes JM Stevenson, JL Reilly, MSH Harris, SR Patel, PJ Weiden, KM Prasad, ... Translational psychiatry 6 (2), e739-e739, 2016 | 58 | 2016 |
| Association of the GGCX (CAA) 16/17 repeat polymorphism with higher warfarin dose requirements in African Americans LH Cavallari, M Perera, M Wadelius, P Deloukas, G Taube, SR Patel, ... Pharmacogenetics and genomics 22 (2), 152-158, 2012 | 52 | 2012 |
| Pharmacogenomics of warfarin dose requirements in Hispanics LH Cavallari, KM Momary, SR Patel, NL Shapiro, E Nutescu, MAG Viana Blood Cells, Molecules, and Diseases 46 (2), 147-150, 2011 | 48 | 2011 |
| Activity of cefiderocol alone and in combination with levofloxacin, minocycline, polymyxin B, or trimethoprim-sulfamethoxazole against multidrug-resistant Stenotrophomonas … M Biagi, A Vialichka, M Jurkovic, T Wu, A Shajee, M Lee, S Patel, ... Antimicrobial agents and chemotherapy 64 (9), 10.1128/aac. 00559-20, 2020 | 45 | 2020 |
| The pharmacokinetics of codeine and its metabolites in Blacks with sickle cell disease SS Shord, LH Cavallari, W Gao, HY Jeong, K Deyo, SR Patel, JR Camp, ... European journal of clinical pharmacology 65, 651-658, 2009 | 36 | 2009 |
| VKORC1 Asp36Tyr geographic distribution and its impact on warfarin dose requirements in Egyptians MHA Shahin, LH Cavallari, MA Perera, SI Khalifa, A Misher, T Langaee, ... Thrombosis and haemostasis 109 (06), 1045-1050, 2013 | 33 | 2013 |
| Association of aldosterone concentration and mineralocorticoid receptor genotype with potassium response to spironolactone in patients with heart failure LH Cavallari, VL Groo, MAG Viana, Y Dai, SR Patel, TD Stamos Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 30 (1), 1-9, 2010 | 32 | 2010 |
| Activity of aztreonam in combination with avibactam, clavulanate, relebactam, and vaborbactam against multidrug-resistant Stenotrophomonas maltophilia M Biagi, D Lamm, K Meyer, A Vialichka, M Jurkovic, S Patel, RE Mendes, ... Antimicrobial Agents and Chemotherapy 64 (12), 10.1128/aac. 00297-20, 2020 | 31 | 2020 |
| Predictors of unstable anticoagulation in African Americans LH Cavallari, JL Aston, KM Momary, NL Shapiro, SR Patel, EA Nutescu Journal of thrombosis and thrombolysis 27, 430-437, 2009 | 30 | 2009 |
